Erlanger and Qventus Partner to Expand Robotic Access and Create Additional OR Capacity

Qventus’ Surgical Growth Solution Modernizes Operations and Alleviates the Administrative Burden on Care Teams for Leading Tennessee-Based Healthcare System NEW YORK–(BUSINESS WIRE)–Erlanger, a nationally-acclaimed, multi-hospital health system, announced today a strategic partnership with Qventus, the industry’s premier provider of AI-based care operations automation software, to drive strategic surgical growth and increase patient access to the … [Read more…]

New Vizient Survey Finds Drug Shortages Cost Hospitals Nearly $900M Annually in Labor Expenses

IRVING, Texas–(BUSINESS WIRE)–Vizient® today announced its updated analysis of the financial impact of drug shortages for hospitals to their workforce and budgets. The new survey, “Beyond the Shortage: The Hidden Cost of Drug Supply Chain Disruptions,” revealed that in 2023, hospitals across the U.S. spent roughly 20 million hours managing a range of drug shortages, … [Read more…]

Mursla Bio Introduces AI Precision Medicine Platform Built on Organ-Specific EV Isolation from Blood

Platform is built on biologically labelled, organ-specific multi-omics data carried by extracellular vesicles isolated from 2ml plasma samples Enables differentiated AI-powered biomarker discovery and IVD translation for patient stratification, therapeutic monitoring, surrogate markers and other diagnostic development programs Publication of pre-print data, with support from Evotec International GmbH and University College London demonstrates validation of … [Read more…]

Amazfit Expands Active 2 Lineup with the New Active 2 Square — All the Same Features, Now in a Sleek Square Design

MILPITAS, Calif.–(BUSINESS WIRE)–#DiscoverAmazing–Amazfit, a leading global smart wearable brand owned by Zepp Health (NYSE: ZEPP), a health technology company, today announced the launch of the square version of the Amazfit Active 2, a new addition to its fitness smartwatch line that offers the same powerful features and premium experience as the recently launched round Active … [Read more…]

Seveno Capital and Borderless Healthcare Group launch JV to provide ‘medical wellness service’ to hospitality owners

The Well Estate will provide a turnkey solution for hospitality asset owners to be able to offer transformative medical wellness experiences to guests as the global hospitality industry seeks to harness the US$1.8 trillion global wellness boom. SINGAPORE–(BUSINESS WIRE)–Seveno Capital and Borderless Healthcare Group have launched the world’s first medical wellness real estate company to … [Read more…]

Feinstein Institutes Awarded $2.3M, Joins Global Bipolar Disorder Research Network

MANHASSET, N.Y.–(BUSINESS WIRE)–To continue its groundbreaking bipolar disorder research, Northwell Health’s The Feinstein Institutes for Medical Research has been awarded $2.3 million and joined the Breakthrough Discoveries for Thriving with Bipolar Disorder (BD²) Integrated Network, a national collaborative research and clinical care initiative aimed at transforming treatment and care for people living with bipolar disorder. … [Read more…]

PureTech Health: Results of Annual General Meeting

BOSTON–(BUSINESS WIRE)–The Annual General Meeting of PureTech Health plc (Nasdaq: PRTC, LSE: PRTC) (“PureTech Health” or the “Company”) was held at 11 a.m. EDT/4 p.m. BST on Monday, June 16, 2025. All of the resolutions proposed at the Annual General Meeting were duly passed by the shareholders on a poll. The results of the poll, … [Read more…]

Genetic Testing Market Research 2025: Analysis with Forecasts by Applications, Technologies, Products and Users with Executive and Consultant Guides – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Genetic Testing Markets. Global Market Analysis with Forecasts by Applications, Technologies, Products and Users with Executive and Consultant Guides” has been added to ResearchAndMarkets.com’s offering. The genetic testing industry is experiencing unprecedented growth, with its potential proving boundless as it expands across various sectors. This growth is being propelled by advancements in our … [Read more…]

KalVista Pharmaceuticals Presents New Data at the European Academy of Allergy and Clinical Immunology Congress 2025 on the Efficacy of Sebetralstat for the On-demand Treatment of HAE Attacks Among Patients Receiving Long-Term Prophylaxis

–Real-world data highlight significant challenges with LTP adherence, and ongoing reliance on on-demand medications– –In KONFIDENT-S, oral sebetralstat delivered rapid, consistent relief for breakthrough attacks, regardless of long-term prophylaxis mechanism of action– CAMBRIDGE, Mass. & SALISBURY, England–(BUSINESS WIRE)–KalVista Pharmaceuticals, Inc. (Nasdaq: KALV) today announced the presentation of new data at the European Academy of Allergy … [Read more…]